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Abstract
Background: Deoxynivalenol (DON) is a mycotoxin produced by Fusarium species in the field, commonly found
in cereal grains, which negatively affects performances and health of animals. Mycotoxin binders are supposed to
reduce the toxicity of mycotoxins.
Method: The effect of a mycotoxin binder (containing acid-activated bentonite, clinoptilolite, yeast cell walls and
organic acids) on growth performance and gut health was studied. Hundred and twenty weaning piglets were
allocated to 4 treatments, with 5 pens of 6 piglets each, arranged in a 2 × 2 factorial design: control diet; control
diet with 1 kg/t binder; control diet with DON; and control diet with DON and 1 kg/t binder. From d0–14,
the diet of DON-challenged groups was artificially contaminated with a mixture of DON (2.6 mg/kg), 3-acetyl-
deoxynivalenol (0.1 mg/kg) and 15-acetyl-deoxynivalenol (0.3 mg/kg), after which the total contamination level
was reduced to 1 mg/kg, until d37. On d14, one pig from each pen was euthanized and distal small intestinal
mucosa samples were collected for the assessment of intestinal permeability, and gene expression of tight
junction proteins, toll-like receptor 4, inflammatory cytokines and intestinal alkaline phosphatase.
Results: After 37 d, there were no differences in growth performance between control and DON-challenged
groups (P > 0.05). Nevertheless, groups that received diets with binder had a significantly higher average daily gain
(ADG) and average daily feed intake (ADFI) for the first 14 d as well as for the whole period, compared to groups
without binder (P ≤ 0.05). Groups with binder in the diet also exhibited lower expression of toll-like receptor 4 in
distal small intestinal mucosa at d14, compared to groups without binder (P ≤ 0.05). Interestingly, comparing the
two DON treatments, piglets fed DON and binder had significantly higher ADFI and ADG compared to those with
only DON for the first 14-d (P ≤ 0.05). Addition of binder to DON contaminated diets, also down-regulated the
gene expression of toll-like receptor 4 (P ≤ 0.05) and increased mRNA level zona occludens 1 (P ≤ 0.10) as
compared to DON.
Conclusions: The present data provide evidence that the binder improves growth rate in piglets associated with
reduction of toll-like receptor-4 and increase of tight junction protein gene expression. However, the current study
does not allow to assess whether the effects of the binder are mediated by alterations in the toxicokinetics of the
mycotoxin.
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Background
The contamination of feedstuffs with mycotoxins is a
worldwide issue. Mycotoxins are harmful secondary
metabolites of fungi which can cause intoxications at
very low dosage. Deoxynivalenol (DON) is a type B
trichothecene mycotoxin, produced by Fusarium spe-
cies. DON is noted for two typical toxicological effects:
reduced feed intake and induction of emesis in swine.
Under natural conditions, DON is present along with
its two major acetylated forms, 3-acetyl-deoxynivalenol
(3A–DON) and 15-acetyl-deoxynivalenol (15A–DON)
at lower concentrations than DON in cereals [1]. DON
is physically stable and can easily enter the food chain
[2]. Humans and all animal species can exhibit toxic
effects after exposure to DON [3], with pigs being the
most susceptible species [4].
The intestinal mucosa is constantly challenged by
various chemical and biological contaminants, and
functions as a vital barrier between the intestinal milieu
and the luminal content [5, 6]. After consumption of
feed contaminated with DON, the intestine can be ex-
posed to high levels of the toxin [7]. Studies show that
DON can affect the intestinal histology and morph-
ology by affecting intestinal cell viability and prolifera-
tion. DON is also able to regulate the production of
pro-inflammatory cytokines, increasing the expression
of interleukin 1 beta (IL-1β), interleukin 2 (IL-2) and
interleukin 6 (IL-6) in the jejunum, and IL-1β, IL-6 and
tumor necrosis factor alpha (TNF-α) in the ileum in pigs
[8]. An in vitro study indicated that DON is able to
decrease transepithelial electrical resistance (TEER) and
increase the permeability of IPEC-1 cells in a dose and
time dependent manner [7]. The alterations in these two
parameters are related to the decreased expression of spe-
cific tight junction proteins (TJPs) 9 [7, 9]. In the intestinal
epithelium, the activation of mitogen-activated protein
kinase (MAPK) by DON and its acetylated derivatives
suppresses the expression of TJPs, which is responsible for
the loss of barrier function [10, 11].
In order to solve the problem caused by mycotoxico-
sis, various strategies have been developed, including
physical, chemical, and biological methods [12, 13]. The
most common approach is the addition of mycotoxin
binders to feeds [14]. Mycotoxin binders are large weight
molecules, capable of binding to mycotoxins in animal
feeds. These binder-mycotoxin complexes pass through
the gastrointestinal tract without dissociating, preventing
mycotoxin uptake [15]. The complex passes through the
GIT and is excreted via the faeces, thereby helping to
minimize absorption of mycotoxins by target organs and
alleviating the adverse effects of mycotoxins.
DON was the most prevalent single mycotoxin found
in all feedstuffs all over the world in 2015 [16]. However,
there are few publications about the effects of toxin
binders on gut health in piglets. This study was con-
ducted to assess the effect of addition of a mycotoxin
binder to the feed on gut health and performance in
pigs following a 37-d dietary exposure to DON.
Methods
Animals and dietary treatments
An animal feeding experiment in a 2 × 2 factorial design
with either or not addition of DON, and either or not
addition of binder to the feed was performed. A total of
120 weaning (24 d of suckling period) piglets with an
average weight of 7.3 kg were used in this study. They
were provided with water and feed ad libitum through-
out the experiment. Animal experimental procedures
were in accordance to the guidelines of the Ethical
Committee of the Faculty of Veterinary Sciences, Ghent
University, Belgium.
Piglets were randomly allocated to 4 dietary treatments.
Each treatment contained 5 pens with 6 piglets per pen.
The 4 treatments were as follows: CON, negative control
diet (uncontaminated basal diet); CON + BIN, negative
control diet with 1 kg/t mycotoxin binder; DON, negative
control diet with DON; DON + BIN, negative control diet
with DON and 1 kg/t mycotoxin binder. The mycotoxin
binder was a blend of indigestible adsorbents that bind
mycotoxins in the GIT (Free-Tox, Nutrex NV, Belgium).
It contains acid-activated bentonite, clinoptilolite, yeast
cell walls and organic acids. From d 0 until d 14 (sampling
on d 14) of the experiment, the diet of DON and
DON + BIN was artificially contaminated with a mixture
of DON (2.6 mg/kg), 3A–DON (0.1 mg/kg) and 15A–
DON (0.3 mg/kg), after which the DON contamination
level was reduced to 1 mg/kg from d 14 until d 37. The
composition of the negative control wheat-barley-soybean
based diets is given in Table 1. The DON-challenge diets
were artificially contaminated with a fungal culture con-
taining DON and its metabolites. DON was produced in
vitro by F. graminearum. After growing up of the mold,
the amount of DON was quantified by ELISA assay on the
medium. The result was verified by LC/MS/MS on the
certified standard blank wheat [17]. Results showed that
the medium contained 240 mg/kg total DON metabolites
(87.5% DON, 2.7% 3A–DON and 9.8% 15A–DON). All
other mycotoxins were under the detection limit. Based
on the concentration in the medium, the amount of
medium needed for 3 mg/kg and 1 mg/kg in pre-starter
and starter diets, respectively, was calculated. After
homogenization, the medium was mixed into the basal
diet. Three mg/kg for pre-starter period (from d 0 until d
14) was chosen because typically feed contamination with
2–5 mg/kg DON is required to induce reduction of feed
intake and decrease of body weight gain [18]. It was fur-
ther reduced to 1 mg/kg for the starter period (from d 14
until d 37) as model for chronic exposure.
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Sampling
After 14 d of feeding, one pig out of each pen was eutha-
nized by intra-peritoneal pentobarbiturate overdose. The
GIT was removed and the small intestine was exposed for
sample collection. A 10-cm segment from the 75% length
of the small intestine (distal small intestine) was collected
for Ussing chamber measurements following flushing with
saline to remove residual content. Another 20 cm segment
from the same region was flushed with saline, placed on a
cold plate and slit longitudinally. Then, mucosa was
harvested by scraping with a glass-slide followed by snap
freezing and storage at −80 °C pending gene expression
analysis.
Growth performance
The weight of piglets as well as the feed intake per pen
were determined at d0, d14 and d37. Average Daily Gain
(ADG, g/d), Average Daily Feed Intake (ADFI, g/d) and
Feed to Gain ratio (F:G) were calculated for periods d0-
d14, d14-d37 and d0-d37. Diarrhoea and mortality were
daily checked and recorded.
Ex vivo measurement of intestinal permeability
Permeability was assessed ex vivo in Ussing chambers by
measuring the permeability for the macromolecular
marker fluorescein isothiocyanate-dextran 4 (FD4, mo-
lecular weight 4 kDa) across sheets of mucosa as described
by Wang et al. [19]. Briefly, fresh segments of mucosa
samples from the distal small intestine (75% of the total
small intestinal length) were separated from the seromus-
cular layer and mounted in the Ussing chamber system.
Intestinal sheets were bathed in 6.5 mL Ringer buffer solu-
tion with 6 mmol/L glucose and 6 mmol/L mannitol in
the serosal and mucosal sides, respectively. The system
was maintained at 37 °C and oxygenated (95% O2 and 5%
CO2). After a 20-min equilibration period, 0.8 mg/mL
FD4 (Sigma-Aldrich, Bornem, Belgium) was added to the
mucosal side. Samples from the serosal compartment
Table 1 Composition of the negative control diet (CON) for pre-starter (d0-d14) and starter (d14-d37) periods
Pre-starter Starter
Ingredients % Ingredients %
Wheat 22.57 Barley 25.00
Barley 22.50 Wheat 22.93
Whey 7.00 Corn 15.00
Extruded soybeans 2.40 Toasted soybeans 12.00
Calcium formiate and lactic acid 1.00 Whey 4.20
Potato protein 2.00 Extruded soybeans 1.70
Toasted soybeans 12.00 Calcium formiate and lactic acid 0.50
Extruded oats and barley 10.00 Coconut 0.20
Corn 7.50 Soybean meal, CP49 9.07
Soybean meal, CP49 4.04 Wheat gluten feed 2.69
Fat, > 88% triglycerides 0.50 Beet pulp, sugar 72% 2.00
Sodium bicarbonate 0.30 Fat, > 88% triglycerides 0.95
Organic acids mixturea 0.30 Organic acids mixturea 0.30
Lime fine 0.29 Salt 0.05
Premixb 7.60 Premixc 3.40
Composition Composition
NE, kcal/kg 2350 NE, kcal/kg 2350
Crude protein, g/kg 173 Crude protein, g/kg 178
Crude fibre, g/kg 37 Crude fibre, g/kg 38
Calcium, g/kg 5.2 Calcium, g/kg 7.9
Phosphorus, g/kg 4.5 Phosphorus, g/kg 4.8
Sugar + Starch, g/kg 457 Sugar + Starch, g/kg 438
aOrganic acids mixture: contains formic acid, phosphoric acid and citric acid
bProviding per kg of complete diet: Vitamin A, 15,000 IU/kg; Vitamin D3 2000 IU/kg; Vitamin E, 200 IU/kg; Vitamin K3, 4.0 mg; Vitamin B1, 3.0 mg; Vitamin B2,
8.0 mg; Vitamin B3, 20 mg; Vitamin B6, 6.0 mg; Vitamin B12, 50.0 μg; niacinamide, 40.0 mg; folic acid, 2.0 mg; biotin, 0.3 mg; Cu, 155 mg/kg; Fe, 150 mg/kg; Mn,
49 mg/kg; Zn, 104 mg/kg; I, 1.55 mg/kg; Se, 0.40 mg/kg
cProviding per kg of complete diet: Vitamin A, 15,000 IU/kg; Vitamin D3 2000 IU/kg; Vitamin E, 102 IU/kg; Vitamin K3, 4.0 mg; Vitamin B1, 3.0 mg; Vitamin B2,
8.0 mg; Vitamin B3, 20 mg; Vitamin B6, 6.0 mg; Vitamin B12, 50.0 μg; niacinamide, 40.0 mg; folic acid, 2.0 mg; biotin, 0.3 mg; Cu, 155 mg/kg; Fe, 150 mg/kg; Mn,
49 mg/kg; Zn, 80 mg/kg; I, 1.49 mg/kg; Se, 0.40 mg/kg
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were taken at 20 min intervals for 80 min to monitor
mucosal-to-serosal fluxes of FD4. Fluorescence inten-
sity of FD4 was determined by fluorescence spectro-
photometry (Thermo Fisher Scientific, Marietta, OH,
USA). The flux over the 100 min period was calculated
and expressed as an apparent permeability coefficient
as described before [19].
RNA isolation and reverse-transcription quantitative
real-time PCR
Relative mRNA expression of TJPs (ZO-1, ZO-2, OCLN,
CLDN-1, CLDN-2, CLDN-5, CLDN-7) and pro-inflam-
matory cytokines (TNF-α, IFN-γ, IL-1β, IL-8), toll-like re-
ceptor 4 (TLR-4) and a brush border enzyme intestinal
alkaline phosphatase (IAP) were determined by reverse
transcription quantitative real-time PCR (RT-qPCR) and
performed according to the MIQE guidelines. Briefly, mu-
cosal total RNA was extracted using the Bio-Rad Aurum
Total RNA Fatty and Fibrous Tissue Kit (Bio-Rad Labora-
tories, Inc., Hercules, CA, USA) according to the man-
ufacturer’s instructions, including an on-column DNase
I treatment to remove genomic DNA (gDNA). The
concentration and purity (OD260/280) of RNA were
measured with the NanoDrop ND-1000 (NanoDrop
Technologies, Thermo Scientific, Wilmington, DE, USA).
1 μg RNA was analyzed by 1% agarose gel electrophoresis
to check RNA integrity (28S and 18S rRNA bands). In
addition to this assessment, a minus-RT control PCR was
performed using YWHAZ as primer to verify the absence
of any gDNA contamination. Following this,1 μg of high
quality DNA-free RNA was reverse transcribed in the
20 μL reverse-transcription reaction with the ImProm-II
cDNA synthesis kit (Promega, Madison, WI, USA), con-
taining both oligo dT and random primers. The obtained
cDNA was diluted 10 times with molecular grade water
and a control PCR using 2 μL cDNA was performed to
verify the reverse-transcription reaction.
Primers (Table 2) used for genes in the study were
designed with Primer3Plus. The repeats, the secondary
structure and single nucleotide polymorphism in target
sequence were checked with RepeatMarker, mfold and
dbSNP, respectively. All these primer sequences were
gene isoform specific as they were designed based on cer-
tain exon-exon boundaries of published pig gene sequences
corresponding to the accession number. Primers were
then purchased from IDT (Integrated DNA Technologies,
Leuven, Belgium).
The RT-qPCR was performed on the CFX96 Touch
Real-Time PCR Detection System (Bio-Rad Laborator-
ies, Inc.). Briefly, 2 μL cDNA template, 5 μL 2× KAPA
SYBR FAST qPCR Kit Master Mix (Kapa Biosystems,
Inc., Wilmington, MA, USA), 2 μL molecular grade
water, 0.5 μL forward primer and 0.5 μL reverse primer
(5 μmol/L each) were added to a total volume of 10 μL.
The amplification conditions were as follows:1) enzyme
activation and initial denaturation (95 °C for 3 min); 2)
denaturation (95 °C for 20 s) and annealing/extension
and data acquisition (annealing temperature depending









CLDN-1 NM_001244539.1 TATGACCCCATGACCCCAGT GCAGCAAAGTAGGGCACCTC 108 59
CLDN-2 NM_001161638.1 TTCCTCCCTGTTCTCCCTGA CACTCTTGGCTTTGGGTGGT 152 62
CLDN-5 NM_001161636.1 GTGGTCCGCGAGTTCTACGA CTTGACAGGGAAGCCGAGGT 171 60
CLDN-7 NM_001160076.1 GGTCCCCACAAACGTGAAGTA TCACTCCCAGGACAAGAGCA 114 60
HPRT-1 DQ178126 CCGAGGATTTGGAAAAGGT CTATTTCTGTTCAGTGCTTTGATGT 181 60
IAP XM_003133729.3 GGCCAACTACCAGACCATCG CCGACTTCCCTGCTTTCTTG 116 60
IFN-γ NM_213948.1 GCTTTTCAGCTTTGCGTGACT CACTCTCCTCTTTCCAATTCTTCA 166 58
IL-1β NM_214055.1 GCACCCAAAACCTGGACCT CTGGGAGGAGGGATTCTTCA 143 58
IL-8 XM_003361958.3 TGTCAATGGAAAAGAGGTCTGC CTGCTGTTGTTGTTGCTTCTCA 100 60
OCLD NM_001163647.2 CATGGCTGCCTTCTGCTTCATTGC ACCATCACACCCAGGATAGCACTCA 129 65
PPIA NM_214353 CTGAAGCATACGGGTCCTGG TGCCCTCTTTCACTTTGCCA 139 65
TBP DQ178129 GATGGACGTTCGGTTTAGG AGCAGCACAGTACGAGCAA 124 59
TLR-4 NM_001113039.2 TTCTTGCAGTGGGTCAAGGA GACGGCCTCGCTTATCTGAC 135 58
TNF-α NM_214022.1 CATGATCCGAGACGTGGAGC AACCTCGAAGTGCAGTAGGC 151 62
ZO-1 XM_003480423.3 ATCTCGGAAAAGTGCCAGGA CCCCTCAGAAACCCATACCA 172 61
ZO-2 XM_005660148.2 CCAGGAAGCACAGAATGCAA AAGTCTGGCGGGACCTCTCT 148 61
aCLDN-1 claudin-1, CLDN-2 claudin-2, CLDN-5 claudin-5, CLDN-7 claudin-7, HPRT-1 hypoxanthine phosphoribosyltransferase 1, IAP intestinal alkaline phosphatase,
IFN-Ƴ interferon gamma, IL-1β interleukin 1 beta, IL-8 interleukin 8, OCLN occludin, PPIA peptidylprolyl isomerase A, TBP TATA-binding protein, TLR-4 toll-like recep-
tor 4, TNF-α tumor necrosis factor alpha, ZO-1 zona occludens 1, ZO-2 zona occludens 2
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on primer for 40 s) repeated 40 cycles; and 3) dissoci-
ation (melt curve analysis from 70 to 90 °C with 0.5 °C
increment every 5 s).
Primers used in this study were first optimized by
gradient quantitative real-time PCR. A 5-fold dilution
series (5 points, from 1 times to 625 times dilution) of
cDNA as standard curve was included at 3 gradient
temperatures to determine PCR amplification efficiency
and specificity. The standard curve was also included in
each run to determine PCR efficiency. In this study,
PCR amplification efficiencies were consistently between
90% and 110%. Gene-specific amplification was verified by
agarose gel electrophoresis and melting curve analysis.
Efficiency was used to convert the Cq value into raw data
with the highest expressed samples (lowest Cq value) as a
calibrator for the normalization of raw data. The relative
expression was expressed as a ratio of the target gene to
the geometric mean of three stable expressed reference
genes (PPIA, HPRT1 and TBP) [19].
Statistical analysis
After determination of normality and variance homo-
geneity, a general linear model with the fixed effects of
mycotoxin and binder, and the interaction term was
used with Tukey’s test as a multiple comparison test in
SAS Enterprise Guide 7 (SAS Institute, Cary, NC, USA).
P ≤ 0.05 was considered as significant. All data are
expressed as mean ± standard errors.
Principal component analysis (PCA) as described by
Montagne et al. was conducted to work out the vari-
ables that contributed most to the variation between
subjects [20, 21]. In brief, the data of 17 variables were
standardised before the application of PCA. At first, a
scree plot was carried out to fix the number of princi-
pal components to be maintained. Five principal com-
ponents were retained with the eigenvalues >1.0. In
addition, variables that had a correlation coefficient
between variable and all principal components ≤0.5
were excluded. Then, retained variables were grouped into
families to check the correlation. Only the main represen-
tative variable with highest principal component loading,
together with high correlation (r > 0.55; P ≤ 0.05) within
family was retained for the final analysis. Finally, 11
variables entered the final PCA.
Results
Growth performances
Only few pigs from different groups had diarrhoea
problems in the first week of the experiment, likely follow-
ing weaning stress. No case of emesis or mortality were
observed. Overall, no clinical signs of toxicity were found.
There were no significant differences between control
groups (CON and CON + BIN) and DON-challenged
groups (DON and DON + BIN) regarding growth
performances (Table 3). In contrast, pigs supplemented
with binder (CON + BIN and DON + BIN) consumed
more feed (265 g/d vs. 242 g/d) and had a higher growth
(197 g/d vs. 170 g/d) for the first 14-d when compared to
pigs that received diets with no binder (CON and DON)
(P ≤ 0.05). Similarly, for the whole experimental period
d0-d37, groups receiving diets with binder (CON + BIN
and DON + BIN) showed an improved ADG (368 g/d vs.
341 g/d) and ADFI (548 g/d vs. 519 g/d) compared to
groups that received diets without binder (CON and
DON) (P ≤ 0.05). Meanwhile, There was a trend that
groups that received diets with binder (CON + BIN and
DON + BIN) had a lower F:G compared to groups that re-
ceived diets without binder (CON and DON) from d 1
until d 14 of the experiment (P ≤ 0.10). Interestingly,
within DON-challenged piglets, addition of the binder im-
proved performance in the first 14-d of the experiment;
DON contaminated diet supplemented with binder
(DON + BIN) showed higher ADFI compared to diet only
contaminated with DON (DON) (272 g/d vs. 227 g/d)
(P ≤ 0.05). This again resulted in a higher growth rate for
treatment DON + BIN than treatment DON for period
d0–14 (205 g/d vs. 159 g/d) (P ≤ 0.05). Also, pigs supple-
mented with binder (DON + BIN) showed higher body
weight at d14 compared to pigs that received diets with
no binder (DON) (10.18 kg vs. 9.63 kg) (P ≤ 0.05).
Permeability measurements in distal small intestine
Neither mycotoxin level, nor binder addition affected
FD4 fluxes across distal small intestinal sheets
(P > 0.05) (Fig. 1). The mean of control groups (CON
and CON + BIN) was 7.5 × 10−7 cm/s; while the
average value of DON-challenged groups (DON and
DON + BIN) was 7.6 × 10−7 cm/s. On binder level, the
difference of FD4 flux between groups that received
diets with the addition of binder (CON + BIN and
DON + BIN) and groups that received diets without
the addition of binder (CON and DON) was larger
compared to the difference between DON-challenged
and DON-control groups but still not significant.
mRNA expression of tight junction proteins, inflammatory
cytokines and brush border enzyme in distal small
intestine
The gene expressions of TJPs (ZO-1, ZO-2, OCLN,
CLDN-1, CLDN-2, CLDN-5, CLDN-7), pro-inflammatory
cytokines (TNF-α, IFN-γ, IL-1β, IL-8), TLR-4 and IAP in
distal small intestine are described in Table 4. Ingestion of
diets contaminated with or without DON, did not change
the gene expression of TJPs, pro-inflammatory cytokines,
and IAP in distal small intestine (P > 0.05), whereas add-
ing the binder to the diets down-regulated the expression
of TLR-4 (0.72 for CON + BIN and DON + BIN vs 1.00
for CON and DON; P ≤ 0.05). At the same time, there
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was a trend that groups that received the diet with the
addition of binder (CON + BIN and DON + BIN) up-
regulated the expression of CLDN-1 compared to
groups that received diet without the addition of binder
(CON and DON) (P ≤ 0.10). More specifically, TLR-4 gene
expression was down-regulated in the DON contaminated
diet supplemented with mycotoxin binder (DON + BIN)
compared to DON (0.57 vs 1.11; P ≤ 0.05). At the same
time, there was a tendency that DON + BIN up-regulated
the expression of ZO-1 compared to DON (P ≤ 0.10).
Principal component analysis
BWd0, BWd14, ADG d0-d14, FD4 permeability, ZO-1,
ZO-2, OCLN, CLDN-1, CLDN-2, CLDN-5, CLDN-7,
TLR4, TNF-α, IFN-γ, IL-1β, IL-8 and IAP were the 17
variables used in the PCA. After application of a first
PCA, 5 principal components were retained following a
scree plot. BWd0 was the only variable that did not
show high correlation on any principal component and
was excluded. Then, BWd14 and ADG d0-d14 were
grouped into growth performance family, ZO-1, ZO-2,
OCLN, CLDN-1, CLDN-2, CLDN-5 and CLDN-7 were
grouped into TJPs family, and TNF-α, IFN-γ, IL-1β and
IL-8 were grouped into inflammatory cytokines family.
FD permeability, TLR-4 and IAP were considered single
representatives and were retained for final analysis.
Some variables were highly correlated within family. In
growth performance family, ADG d0-d14 was highly
correlated with BWd14 (r = 0.966, P ≤ 0.01), yet ADG
d0–14 was not retained. Within the family of TJPS,
OCLN was correlated with ZO-1 (r = 0.762, P ≤ 0.01),
ZO-2 (r = 0.811, P ≤ 0.01) and CLDN-7 (r = 0.683,
P ≤ 0.01). Then, OCLD, CLDN-1, CLDN-2 and CLDN-5
were retained for the final PCA. For the family of
Fig. 1 Intestinal permeability for FD4 in distal small intestinal mucosa
of piglets fed diets at d14 post-weaning. Data are means ± SE (n = 5).
P for factor mycotoxin is 0.96, for factor binder 0.21, and for mycotoxin
× binder 0.51. CON, negative control diet (uncontaminated basal diet);
CON + BIN, negative control diet with 1 kg/t mycotoxin binder; DON,
negative control diet with DON; DON + BIN, negative control diet with
DON and 1 kg/t mycotoxin binder
Table 3 Growth performance (body weight, BW; average daily gain ADG; average daily feed intake, ADFI, and feed:gain ratio, F:G)
for periods d0-d14 (pre-starter), d14-d37 (starter) and d0-d37 (total) of piglets fed diets with or without mycotoxins, and with or
without binder (n = 5)
Item Treatment1 P-value
CON CON + BIN DON DON + BIN Mycotoxin Binder Mycotoxin
× BinderMean SE Mean SE Mean SE Mean SE
Day 0–14 (pre-starter)
BW d0, g 7.30 0.01 7.31 0.01 7.32 0.01 7.30 0.01 0.52 0.85 0.49
BW d14, g 9.82ab 0.13 9.96ab 0.15 9.63b 0.13 10.18a 0.12 0.97 0.02 0.05
ADG, g/d 181ab 10 188ab 11 159b 10 205a 9 0.80 0.02 0.03
ADFI, g/d 256ab 10 257ab 12 227b 10 272a 10 0.50 0.05 0.05
F:G 1.43 0.04 1.38 0.05 1.43 0.04 1.33 0.04 0.64 0.08 0.25
Day 14–37 (starter)
BW d37, g 20.3 0.43 20.4 0.49 19.9 0.43 21.0 0.40 0.95 0.21 0.35
ADG, g/d 446 17 469 17 444 15 466 13 0.86 0.17 0.55
ADFI, g/d 724 21 760 23 716 21 750 19 0.68 0.11 0.44
F:G 1.59 0.03 1.62 0.03 1.62 0.03 1.62 0.03 0.68 0.55 0.83
Day 0–37 (total)
ADG, g/d 344 14 366 14 337 12 370 11 0.90 0.05 0.21
ADFI, g/d 527 14 548 16 511 14 549 13 0.59 0.05 0.19
F:G 1.50 0.03 1.50 0.03 1.51 0.03 1.49 0.02 0.84 0.63 0.92
Means with different superscripts (a, b) within row represent differences among treatments (P ≤ 0.05)
1CON negative control diet (uncontaminated basal diet), CON + BIN negative control diet with 1 kg/t mycotoxin binder, DON negative control diet with DON,
DON + BIN negative control diet with DON and 1 kg/ton mycotoxin binder
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inflammatory cytokines, only IFN-γ was excluded.
Finally, 11 variables were kept for this final PCA
(Table 5). The 5 principal components explained 85.5%
of the variance, of which the first principal component
contributing 22.6% and the second principal compo-
nent contributing 22.2%. The first principal component
grouped the TJPs family members OCLN, CLDN-1,
CLDN-2 as well as TNF-α and brush border enzyme
IAP together. Principal component 1 had higher princi-
pal component score in groups with addition of binder
(CON + BIN and DON + BIN) compared to groups
without addition of binder (CON and DON) (0.330 vs.
−0.398) (P ≤ 0.10). In other words, ingestion of diets
supplemented with binder tended to be associated with
higher gene expression of OCLN, CLDN-1, CLDN-2,
TNF-α and IAP as compared to diet without binder.
This finding is consistent with the gene expression re-
sult of CLDN-1 in Table 4. It supports the finding that
binder may also co-up-regulate the expression of other
TJPs (OCLN, CLDN-2) and IAP. The second principal
component indicates that the high expression of TLR-4
was associated with high expression of pro-inflammatory
cytokines TNF-α and IL-1β. The third principal compo-
nent denotes that high expression of CLDN-1, CLDN-2
and CLDN-5 was related to higher weight at d14. How-
ever, principal components 2 and 3 were not discrimin-
atory for treatments.
Discussion
In the current experiment, mycotoxin contamination of
piglet diets exhibited no effect on growth and gut health
parameters. In contrast, the addition of a mycotoxin
binder showed beneficial effects, in particular when diets
were contaminated with 3 mg/kg of a mixture of DON
and acetylated metabolites. Growth and feed intake were
enhanced, in line with improvements of some selected
gut health parameters.
Lack of effect of DON addition to feed on performance
and gut health
In addition to lack of effect on growth performance,
our results did not show an effect of DON on gut
health in the distal small intestine, regarding intestinal
permeability and mRNA expression of TJPs and pro-
inflammatory cytokines, as well as IAP, after 14 d of
feeding 3 mg/kg total DON. The lack of effect in the
distal small intestine might be associated with the tox-
icokinetic properties of DON. In vivo and in vitro
studies demonstrated that DON and its acetylated
forms are rapidly absorbed from the upper GIT, in-
volving stomach until proximal jejunum. After chronic
exposure to DON in pigs, a fast and almost complete
absorption (> 90%) occurs, with DON appearing within
15 min in the blood and reaching maximal concentrations
1.65 h after oral exposure [22]. Danicke et al. revealed that
Table 4 Relative mRNA expression of tight junction proteins, pro-inflammatory cytokines and intestinal alkaline phosphatase in
distal small intestinal mucosa of piglets fed diets with or without mycotoxin contamination, and with or without binder at d14
post-weaning (n = 5)
Item1 Treatment2 P-value
CON CON + BIN DON DON + BIN Mycotoxin Binder Mycotoxin
× BinderMean SE Mean SE Mean SE Mean SE
ZO-1 1.50 0.16 1.45 0.18 1.29 0.16 1.88 0.15 0.50 0.12 0.08
ZO-2 1.40 0.17 1.18 0.17 1.13 0.17 1.42 0.15 0.95 0.82 0.50
OCLN 1.09 0.24 0.97 0.24 0.83 0.24 1.60 0.22 0.45 0.18 0.13
CLDN-1 1.10 0.17 1.30 0.15 1.03 0.15 1.36 0.15 0.96 0.10 0.36
CLDN-2 1.68 0.28 1.17 0.28 0.87 0.28 1.25 0.25 0.19 0.81 0.26
CLDN-5 0.95 0.23 1.04 0.23 0.76 0.23 0.66 0.21 0.22 0.98 0.61
CLDN-7 1.83 0.23 1.36 0.23 1.20 0.23 1.62 0.21 0.42 0.92 0.26
TLR-4 0.88ab 0.12 0.87ab 0.12 1.11a 0.14 0.57b 0.11 0.77 0.04 0.05
TNF-α 0.98 0.20 0.84 0.20 0.85 0.20 0.98 0.18 0.99 0.98 0.92
IFN-γ 0.38 0.18 0.30 0.18 0.73 0.18 0.45 0.17 0.18 0.34 0.41
IL-1β 0.97 0.24 0.92 0.24 1.20 0.24 0.79 0.22 0.83 0.34 0.65
IL-8 1.48 0.31 1.00 0.31 0.89 0.31 1.20 0.28 0.54 0.78 0.57
IAP 0.91 0.22 1.00 0.22 0.73 0.22 1.03 0.20 0.72 0.37 0.65
Means with different superscripts (a, b) within row represent differences among treatments (P ≤ 0.05)
1CLDN-1 Claudin 1, CLDN-2 Claudin 2, CLDN-5 Claudin 5, CLDN-7 Claudin 7, IAP Intestinal alkaline phosphatase, IFN-γ Interferon, gamma, IL-1β Interleukin 1 beta, IL-
8 Interleukin 8, OCLN Occludin, TLR-4 Toll like receptor 4, TNF-α Tumor necrosis factor alpha, ZO-1 Zona occludens 1, ZO-2 Zona occludens 2
2CON negative control diet (uncontaminated basal diet), CON + BIN negative control diet with 1 kg/t mycotoxin binder, DON negative control diet with DON,
DON + BIN negative control diet with DON and 1 kg/t mycotoxin binder
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88.5% of the DON dose was detected in the stomach
whereas only 1.5% in the small intestine [23]. Also, the
acetylated derivatives of DON are rapidly hydrolysed to
DON in vivo and then absorbed. Thus, the distal small
intestine might be less susceptible to DON as the ma-
jority of DON is already absorbed in the proximal parts
of the GIT [24]. All animal species can exhibit toxic
effects when exposed to DON [3], with pigs being the
most susceptible species [4]. However, the severity de-
pends on various factors, including type and dose of
DON, the route and duration of application, as well as
the animal status [25]. After application of DON on the
apical side or on the basolateral side of IPEC-J2 cells,
Diesing et al. found that the apical epithelium seems to
be more resistant to DON application while the same
concentration of DON from basolateral side severely
impairs barrier integrity [9]. In our case, it can be as-
sumed that most DON was absorbed in the upper GIT,
reaching the more susceptible basolateral side whereby
only a small part of DON was left in the less susceptible
apical side. That’s probably the reason why little effect
of DON administration on gut health was seen in sam-
ples from the distal small intestine. Also, it should be
taken into account that generally cytokine induction
upon DON exposure occurs within hours of exposure
[26], and thus differences after chronic exposure as in
our study might not always be present.
So far, data about the effects of DON are incomplete, es-
pecially due to the lack of in vivo data. At first, feed natur-
ally contaminated with DON was used in studies in vivo
and in vitro. However, interpretation of data from natur-
ally contaminated diets is complicated as co-occurrence
with other mycotoxins is commonly found in cereals.
Mycotoxicoses may be caused by multiple toxins, making
it difficult to unravel the separate effects of the target
mycotoxin DON. At present, it is challenging to study the
effect of DON and its masked mycotoxins ADONs. Puri-
fied mycotoxins are generally used in in vitro experiments.
In addition, it is difficult to correlate in vitro exposure
with in vivo dosage as the amount of mycotoxin that can
be absorbed in vivo does not necessarily correspond to the
amount absorbed by cells in culture. Taken together, it’s
difficult to conclude what dose DON will exhibit toxic
properties, as the dose, the type of mycotoxin, the route
and duration of exposure can all influence the mode of
action.
Binder addition to the feed improves performance and
some parameters of gut health
The mycotoxin binder used in this study was a combin-
ation of acid-activated bentonite, clinoptilolite, yeast cell
walls and organic acids and salt. Acid-activated bentonite
increases the adsorption capacity by using a specific acid
activation process to increase the surface area and to en-
large pores [27, 28]. Clinoptilolite, with a honeycomb like
structure, serves to bind a broad range of mycotoxins [29].
Yeast cell walls, which contain α-D-mannans and β-D-glu-
cans, have an active role in reducing mycotoxins in animal
feed [30, 31]. Yeast cell walls used in the binder are ex-
tracted and harvested in the early stage of the fermenta-
tion, during which the network of covalent bonds is less
dense, which offers more flexibility and a maximal accessi-
bility of the mycotoxin binding sites [32–34].
In the current study, the ingestion of diets supple-
mented with binder reduced the expression of TLR-4
compared to diets with no binder. TLR-4 plays an
important role in recognizing Gram-negative bacteria
and activation of the innate immune system. Activation
of TLR-4 leads to the release of its downstream
Table 5 Loadings and principal component scores for 5 principal
components obtained by principal component analysis a (PCA) of
11 variables from piglets fed diets with or without mycotoxin
contamination, and with or without binder at d14 post-weaning
Treatmentb Principal component
1 2 3 4 5
22.6% 22.2% 16.0% 15.6% 10.1%
CON −0.225 0.119 0.119 0.719 0.517
CON + BIN −0.019 0.006 0.390 −0.327 −0.455
DON −0.571 0.630 −0.366 −0.477 0.119
DON + BIN 0.679 −0.630 −0.120 0.071 −0.151
P-value
Mycotoxin 0.68 0.88 0.29 0.36 0.92
Binder 0.10 0.12 0.58 0.56 0.18





CLDN-2 0.343 0.335 0.754
CLDN-5 0.546 0.713
TLR-4 0.891




aRotation method: varimax with Kaiser normalisation; only correlations with
|r| > 0.3 are indicated
bCON negative control diet (uncontaminated basal diet), CON + BIN negative
control diet with 1 kg/t mycotoxin binder, DON negative control diet with
DON, DON + BIN negative control diet with DON and 1 kg/t mycotoxin binder.
Principal components scores of subjects were analysed by General Linear
model with fixed factor mycotoxin addition, binder addition and
the interaction
cBW body weight, CLDN-1 Claudin 1, CLDN-2 Claudin 2, CLDN-5 Claudin 5, FD4
FITC-dextran 4, IAP Intestinal alkaline phosphatase, IL-1β Interleukin 1 beta, IL-8
Interleukin 8, OCLN Occludin, TLR-4 Toll like receptor 4, TNF-α Tumor necrosis
factor alpha
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inflammatory modulators, including TNF-α and IL-1
[35]. This mechanism is well known and supported in
the present study by the positive association between
TLR-4, TNF-α and IL-1β mRNA expression that was
evident in principal component 2 from the PCA. TLR-4
is most well-known for recognizing lipopolysaccharides
(LPS), a structural component of the outer membrane
of Gram-negative bacteria. LPS induce strong inflam-
matory responses in vivo, and are released when the
cell is lysed or during bacterial cell division. Supple-
mentation of toxin binders has shown reduced expres-
sion of pro-inflammatory cytokines such as IL-1β and
IL-6 and other immune responses in LPS-induced pigs
[36]. In other words, the mycotoxin binder might not
only bind to mycotoxins, but might also bind other
toxins such as bacterial endotoxins. This was not spe-
cifically investigated in the present study but might
have occurred.
At the same time, there was a tendency that the sup-
plementation of binder up-regulated the expression of
CLDN-1. Claudins function as major components of the
tight junction strands that regulate the permeability of
epithelia. CLDN-1, a member of the claudin family, is an
integral membrane protein. Enhanced CLDN-1 expres-
sion can decrease paracellular permeability and tighten
the tight junctions. As the mycotoxin binder in the
current study may have adsorbed a range of toxins, it
could be hypothesized that it adsorbed other xenobiotics
which might impair the barrier function by deregulation
of TJ assembly.
From the result of PCA, we know that groups with
the supplementation of binder tended to have higher
scores for principal component 1, which is positively
associated with gene expression of OCLN, CLDN-1,
CLDN-2 and IAP, as compared to diets without binder.
This finding is consistent with the gene expression
result of CLDN-1. The PCA suggests that binder may
also up-regulate the expression of other TJPs (OCLN,
CLDN-2) and IAP. OCLD, together with the claudin
group of proteins, is an important component of the
tight junctions. Studies have shown that rather than be-
ing important in assembly and maintenance of tight
junctions, OCLN is important in stability and barrier
function of tight junctions. As the OCLN gene is essen-
tial and plays a fundamental role in modulating the
epithelial tight junctions, OCLN is a respective marker
of epithelial barrier and its presence or absence could
reflect the permeability of intestinal epithelium [37].
Taken the correlation into consideration, the binder
may stimulate the expression of other TJPs as OCLN is
highly correlated to ZO-1, ZO-2 and CLDN-7. The
family of ZO is a part of the cytoplasmic plaque of the
TJPs. The importance of maintenance of gut barrier
integrity is further illustrated by the grouping of weight
at d14 and the mRNA levels of claudins within princi-
pal component 3.
IAP is a brush border enzyme which is a component of
the gut mucosal defence system. IAP is involved in regu-
lating secretion of bicarbonate in the duodenum. Failure
to neutralize acid environment can lead to acidified chyme
injuring epithelial cells, finally increasing inflammation
and intestinal permeability. IAP is also known to detoxify
LPS and prevent bacterial translocation in the gut [38]. As
discussed, LPS will induce strong inflammatory responses
in vivo. In other words, IAP can inhibit the inflammatory
responses by detoxification of LPS. So, IAP is an import-
ant indicator to gut health.
Taken together, the addition of mycotoxin binder
could improve the gut health by decreasing the expres-
sion of TLR-4 as well as increasing the expression of
TJPs and IAP.
Conclusions
The addition of a mycotoxin binder showed beneficial
effects for weaned piglets, especially when diets were
contaminated with 3 mg/kg of a mixture of DON in the
pre-starter period. Growth and feed intake were enhanced.
In line with this, reduced toll-like receptor-4 and increase
of tight junction protein gene expression might shed light
on the mode of action of the binder. However, the current
study does not allow to assess whether the effects of the
binder are mediated by alterations in the toxicokinetics of
the mycotoxin.
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